Document Detail


Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
MedLine Citation:
PMID:  11436188     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The relationship between insulin-mediated glucose disposal and daylong free fatty acid (FFA) concentrations before and after sibutramine-assisted weight loss was investigated in 24 healthy, normotensive, nondiabetic, obese women (body mass index [BMI] >30.0 kg/m(2)). The 24 volunteers were defined as being insulin-resistant (IR) or insulin-sensitive (IS) on the basis of their steady-state plasma glucose (SSPG) concentration in response to a 180-minute continuous intravenous infusion of octreotide, insulin, and glucose. The mean (+/- SEM) SSPG concentrations were significantly higher (P <.001) in the IR group (219 +/- 7 v 69 +/- 6 mg/dL) at baseline. The IR group also had significantly higher plasma glucose (P =.002), insulin (P <.001), and FFA (P =.02) concentrations measured at hourly intervals from 8 AM to 4 PM, before and after breakfast (8 AM) and lunch (noon). Weight loss in response to an energy-restricted diet for 4 months and sibutramine (15 mg/d) was comparable in the 2 experimental groups (8.6 +/- 1.3 v 7.9 +/- 1.4 kg). SSPG concentrations decreased significantly (P <.001) following weight loss (219 +/- 7 to 144 +/- mg/dL) in the IR group, but there was no change in the SSPG of the IS group (69 +/- 6 to 73 +/- 7 mg/dL. The improvement in insulin sensitivity in the IR group after weight loss was associated with a significant decline in daylong plasma glucose (P >.001) and insulin (P =.02) concentrations, without a weight-loss-associated decrease in daylong plasma FFA responses. In contrast, there was no significant change in plasma glucose, insulin, and FFA concentrations following weight loss in the IS group. These results indicate that daylong FFA concentrations vary substantially in obese individuals as a function of whether they are IR or IS. Furthermore the observation that the IR group was more insulin-sensitive after weight loss, associated with lower daylong insulin concentrations in the absence of a significant decrease in circulating FFA concentrations, suggests that resistance to insulin-mediated glucose disposal in obese individuals cannot be entirely due to high FFA levels.
Authors:
T McLaughlin; F Abbasi; C Lamendola; H S Kim; G M Reaven
Related Documents :
3517028 - Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrat...
12561948 - Pharmacokinetic study of niosome encapsulated insulin.
17062758 - Chronic treatment with pioglitazone does not protect obese patients with diabetes melli...
11120658 - Reference intervals for glucose, beta-cell polypeptides, and counterregulatory factors ...
1909248 - Alteration in the temporal organisation of insulin secretion in type 2 (non-insulin-dep...
23899518 - Placenta mesenchymal stem cell accelerates wound healing by enhancing angiogenesis in d...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Metabolism: clinical and experimental     Volume:  50     ISSN:  0026-0495     ISO Abbreviation:  Metab. Clin. Exp.     Publication Date:  2001 Jul 
Date Detail:
Created Date:  2001-07-03     Completed Date:  2001-08-02     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0375267     Medline TA:  Metabolism     Country:  United States    
Other Details:
Languages:  eng     Pagination:  819-24     Citation Subset:  IM    
Copyright Information:
Copyright 2001 by W.B. Saunders Company
Affiliation:
Department of Medicine, Stanford University, School of Medicine, Stanford, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adipose Tissue / metabolism
Appetite Depressants / administration & dosage*
Blood Glucose / analysis
Body Mass Index
Cyclobutanes / administration & dosage*
Fatty Acids, Nonesterified / blood,  metabolism*
Female
Humans
Insulin / blood
Insulin Resistance*
Lipolysis
Middle Aged
Obesity / blood,  physiopathology*
Weight Loss*
Grant Support
ID/Acronym/Agency:
DK-30732/DK/NIDDK NIH HHS; RR-000700/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Appetite Depressants; 0/Blood Glucose; 0/Cyclobutanes; 0/Fatty Acids, Nonesterified; 106650-56-0/sibutramine; 11061-68-0/Insulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pathophysiologic phenotypes of Japanese subjects with varying degrees of glucose tolerance: using th...
Next Document:  Correlation between carotid artery distensibility and serum vascular endothelial growth factor conce...